Stockreport

Baron Health Care Fund Q4 2025 Contributors And Detractors [Seeking Alpha]

Doximity, Inc. Class A  (DOCS) 
PDF Cidara Therapeutics' shares rose further following Merck's acquisition of the company in a $9.2 billion all-cash deal announced in November 2025, representing a premium [Read more]